JPH02258725A - Preventive and treating agent for animal pseudorabies - Google Patents

Preventive and treating agent for animal pseudorabies

Info

Publication number
JPH02258725A
JPH02258725A JP1076621A JP7662189A JPH02258725A JP H02258725 A JPH02258725 A JP H02258725A JP 1076621 A JP1076621 A JP 1076621A JP 7662189 A JP7662189 A JP 7662189A JP H02258725 A JPH02258725 A JP H02258725A
Authority
JP
Japan
Prior art keywords
pseudorabies
administration
crude drugs
active ingredients
animals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1076621A
Other languages
Japanese (ja)
Other versions
JP2701930B2 (en
Inventor
Kiyoshi Koga
古閑 淑
Yoshihiro Yahara
矢原 芳博
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nisshin Seifun Group Inc
Original Assignee
Nisshin Seifun Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nisshin Seifun Group Inc filed Critical Nisshin Seifun Group Inc
Priority to JP1076621A priority Critical patent/JP2701930B2/en
Publication of JPH02258725A publication Critical patent/JPH02258725A/en
Application granted granted Critical
Publication of JP2701930B2 publication Critical patent/JP2701930B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

PURPOSE:To obtain a remedy for preventing and treating pseudorabies containing specific crude drugs as active ingredients without causing any problems in formation of strongly toxic viruses and residual vaccine, etc., in animal bodies caused by administration of the vaccine. CONSTITUTION:A preventive and treating agent containing one or two or more crude drugs selected from the group consisting of Caryophylli Flos, Schizonepetae Spica, Artemisiae Folium, Perilla Herba, Rhei Rhizoma, Glycyrrhizae Radix, Moutan Cortex, Paeoniae Radix, Houttuyniae Herba, Artemisiae Capillaris Spco, Loniceras Flos, Cinammoni Cortex, Eucommiae Cortex, Eriobotryae Folium and Forysythiae Fructus as active ingredients. The crude drugs are administered and used in the form of intact crude drug parent chemicals, cut substances thereof, roughly crushed, powdery or granular substances, extract solution obtained by extracting active ingredients of the crude drugs with water or other solvents, diluted or concentrated extracted solutions. The dose thereof is 0.001-10g/kg/day for oral administration and 0.01mg to 1g/kg/day for parenteral administration expressed in terms of the dried crude drug parent chemicals.

Description

【発明の詳細な説明】 [産業上の利用分野] 本発明は、動物の仮性狂犬病の予防および治療剤に関す
る。詳細には特定の生薬を活性成分として含有する動物
の仮性狂犬病の予防および治療剤である。
DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to an agent for preventing and treating pseudorabies in animals. Specifically, it is a preventive and therapeutic agent for pseudorabies in animals that contains a specific crude drug as an active ingredient.

[従来の技術] 仮性狂犬病(Pseudorabies)はヘルペスウ
ィルスの1種によって引き起こされる急性伝染病であり
、かかるウィルスの発見者であるオーエスキー(Auj
eszki)の名に因んでオーエスキー病とも呼ばれて
いる。
[Prior Art] Pseudorabies is an acute infectious disease caused by a type of herpes virus.
It is also called Aujeski's disease, after the name of the disease.

この病気には豚、牛、馬、山羊、めん羊、うさぎ、犬、
猫、ミンク、狐、ネズミ等の動物が罹患し、豚以外の動
物では激しい局所性の掻痒症状を示し病状が進行すると
延髄、咽頭、顎等の麻痺、流誕、呼吸困難、8搏の乱れ
等を生じ高率で死亡する。豚の場合は、成育豚ではこの
病気への感受性が高いにも拘らず症状が軽く回復するこ
とが多いが、幼若な子豚では症状が重くなり上記の他の
動物の場合と同様に致死率が高い。
This disease affects pigs, cows, horses, goats, sheep, rabbits, dogs,
Cats, mink, foxes, rats, and other animals are affected, and animals other than pigs exhibit severe localized itching symptoms, and as the disease progresses, paralysis of the medulla oblongata, pharynx, jaw, etc., ejaculation, difficulty in breathing, and disordered rhythms occur. etc., resulting in a high rate of death. In the case of pigs, although the symptoms are mild in adult pigs despite their high susceptibility to this disease, symptoms often recover, but in young piglets the symptoms become severe and can be fatal, as in the case of the other animals mentioned above. rate is high.

かかる仮性狂犬病の予防及び治療法としては、従来、仮
性狂犬病に罹患した動物およびそれに接触した動物を速
やかに隔離すると共に媒介となるネズミを駆除する、飼
育者、畜舎、器物、飼料等による伝染を防止するために
消毒等の必要な処置を行う等の方法が、主として採用さ
れてきたが、手間がかかるにも拘らず充分満足し得る結
果が得られなかった。
Conventional methods for preventing and treating pseudorabies include immediately isolating animals infected with pseudorabies and animals that have come into contact with them, and exterminating rats that act as vectors to prevent transmission through breeders, livestock pens, equipment, feed, etc. In order to prevent this, methods such as performing necessary measures such as disinfection have mainly been adopted, but although it is time-consuming, it has not been possible to obtain sufficiently satisfactory results.

また、高度免疫馬血清またはそれを精製したγ−グロブ
リンの注射はある程度の予防および治療効果があるがや
はり確実なものではなかった。更に、弱毒性のワクチン
の投与も試みられているが、発病は阻止し得ても感染を
阻止し得ず、逆に強毒性ウィルスのキャリアーの形成、
ワクチンの動物体内での残留等の弊害があり実用面で問
題が多かった。
In addition, although injections of hyperimmune horse serum or γ-globulin purified from it have some preventive and therapeutic effects, they are still not reliable. Furthermore, attempts have been made to administer weakly virulent vaccines, but although they may be able to prevent the onset of the disease, they cannot prevent infection; on the contrary, they may cause the formation of highly virulent virus carriers,
There were many problems in practical use due to the adverse effects of the vaccine remaining in the animal's body.

[発明の内容] 本発明者等は、予防および治療効果が高く且つ手間等が
かからず、しかもワクチンを投与した場合に生じる強毒
性ウィルスの形成や動物体内でのワクチンの残留等の問
題の無い仮性狂犬病の予防および治療剤について研究を
続けてきた。その結果、多数ある生薬のうちの特定のも
のが、かかる仮性狂犬病の予防および治療に極めて有効
であることを見出して本発明を完成した。
[Contents of the Invention] The present inventors have discovered a method that has high preventive and therapeutic effects, requires little effort, and also eliminates problems such as the formation of highly virulent viruses and vaccine residue in the animal body when administered. We have been conducting research on preventive and therapeutic agents for pseudorabies. As a result, the present invention was completed based on the discovery that a specific one among the many herbal medicines is extremely effective in preventing and treating pseudorabies.

したがって、本発明は、丁字、荊芥、文集、蘇葉、大賞
、甘草、牡丹皮、づ薬、十薬、菌陳高、金銀花、桂皮、
杜仲、枇杷葉および連翹からなる群から選ばれる生薬の
1種または2種以上を活性成分として含有することを特
徴とする動物の仮性狂犬病の予防および治療剤である。
Therefore, the present invention includes clove, peony, Wen Shu, Su Ye, Dasho, Licorice, Peony Peel, Zhu medicine, Ten medicines, Fungus Chen Gao, Gold and Silver Flower, Cinnamon Peel,
This is a prophylactic and therapeutic agent for pseudorabies in animals, characterized by containing as an active ingredient one or more crude drugs selected from the group consisting of Morifolia, Loquat, and Liancao.

丁字、荊芥、交葉、蘇葉、大賞、甘草、牡丹皮、万薬、
十薬、菌陳高、金銀花、桂皮、杜仲、枇杷葉および連翹
は、いずれも人間用の生薬として従来から知られている
ものであるが、かかる生薬が動物の仮性狂犬病の予防お
よび治療に有効であることはこれまで何ら知られておら
ず、したがって本発明はかかる生薬の既知の効能からは
全く予想外の発見に基づくものである。
Clove, peony, mixed leaves, soba, grand prize, licorice, peony skin, ten thousand medicines,
The ten medicines, Bacteria Chengao, Jinyinhua, Cinnamon bark, Du Zhong, Loquat leaf, and Lianyu are all conventionally known as herbal medicines for humans, and these herbal medicines are useful for the prevention and treatment of pseudorabies in animals. It has not been known to be effective, and the present invention is therefore based on a completely unexpected discovery based on the known efficacy of such herbal medicines.

以下に、本発明で使用する上記の生薬について簡単に説
明する。
Below, the above-mentioned crude drugs used in the present invention will be briefly explained.

丁字(チョウジ)  (Caryophylli Fl
os):丁字の開花直前のつぼみであり、成分としてオ
イゲノール、アセチルオイゲノール等を含み、ヒトの健
胃薬、駆虫薬、香辛料、化粧品等として使用されている
Clove (Caryophylli Fl)
os): The bud of a clove tree just before flowering. It contains eugenol, acetyl eugenol, etc. as ingredients, and is used as a stomachic, anthelmintic, spice, cosmetics, etc.

荊芥(ケイガイ) (Schizonepetae 5
pica) :荊芥の花穂であり、成分としてメントン
、リモネン等を含有し、ヒトの鎮痛薬、抗炎症薬等とし
て使用されている。
Schizonepetae 5
pica): It is the flower spike of the sagebrush, and contains menthone, limonene, etc. as ingredients, and is used as an analgesic and anti-inflammatory drug for humans.

文集(ガイヨウ) (Artemlsiae Foli
um):丈(ヨモギ)またはやま文の葉であり゛、成分
としてユーカリブトールセスキテルペン等を含み、ヒト
の止血、強壮、補血薬等として使用されている。
Collection of Literature (Artemlsiae Foli)
um): Leaves of Mugwort or Yamabun. Contains eucalybutol sesquiterpene and other ingredients, and is used as a hemostasis, tonic, and blood supplement for humans.

蘇葉(ンヨウ) (Perillae Herba) 
:紫蘇の葉であり、成分としてアントシアン色素1.リ
モネン等を含有し、ヒトの鎮静剤、鎮咳剤等として、ま
t;抗菌剤として使用されている。
Perillae Herba
: Perilla leaves, with anthocyanin pigment as a component. Contains limonene, etc., and is used as a human sedative, antitussive, etc., and as an antibacterial agent.

大賞(ダイオウ) (Rhei Rhizoma) :
大賞および近縁植物の根茎の外層を剥ぎそのまま又は縦
割しI;ものであり、成分としてオキシアントラキノン
誘導体であるクリソファン酸、エモジン、イモジンモノ
エチルエーテル等ヲ含有し、ヒトの健胃苦味薬、緩下薬
、消炎薬等として使用されている。
Grand Prize (Rhei Rhizoma):
The outer layer of the rhizome of Grand Prize and related plants is peeled as is or vertically divided; it contains the oxyanthraquinone derivatives chrysophane acid, emodin, imodine monoethyl ether, etc., and has a bitter taste that is good for the human stomach. It is used as a medicine, laxative, anti-inflammatory, etc.

甘草(カンゾウ) (Glycyrrhizae Ra
dix) :甘草の根であり、成分としてグリシルリチ
ン等を含有し、ヒトの矯味剤、鎮咳去痰薬等として使用
されている。
Licorice (Glycyrrhizae Ra)
dix): Licorice root, containing glycyrrhizin and other ingredients, and is used as a flavoring agent, antitussive expectorant, etc. for humans.

牡丹皮(ボタンヒ) (Moutan Cortex)
:牡丹の根皮であり、成分としてペオノール、安息香酸
等を含有し、ヒトの鎮痛薬、鎮痙薬等として使用されて
いる。
Moutan Cortex
: Root bark of peony, contains ingredients such as paeonol and benzoic acid, and is used as an analgesic and antispasmodic for humans.

荀薬(シャクヤク) (Paeoniaa Radix
) :づ薬の根であり、成分として安息香酸等を含有し
、ヒトの鎮痛薬等として使用されている。
Paeoniaa Radix
): The root of the drug, which contains benzoic acid and other ingredients, and is used as an analgesic for humans.

十薬(ジュウヤク) (Houttuynias He
rba) :ドクダミの全軍であり、成分としてフェル
シトリン、メチルノニルケトン、カプリン酸等を含有し
、ヒトの創傷、尿道炎に対する炎症薬等として使用され
ている。
Houttuynias He
rba): This is the whole family of Heutyami, which contains fercitrin, methyl nonyl ketone, capric acid, etc. as ingredients, and is used as an inflammatory drug for human wounds and urethritis.

mri*cインチンコウ)(Ar’t、amisiae
 CapillarisSpco) : 菌陳高はカワラヨモギの穂であり、成分としてカビラリ
ン、カビラリシン等を含有し、ヒトの消炎、解熱、利尿
薬として使用されている。
mri*c chinko) (Ar't, amisiae
Capillaris Spco): Capillaris Spco is an ear of mugwort, contains kabilarin, kabilarisin, etc. as ingredients, and is used as an anti-inflammatory, antipyretic, and diuretic for humans.

金銀花(キンギン力) (Lonicerae Flo
s) :スイカズラのつぼみであり、成分としてルテオ
リン等を含有し、ヒトの浄血、解毒薬として使用されて
いる。
Lonicerae Flo
s): Honeysuckle bud, contains luteolin and other ingredients, and is used as a blood purifier and antidote for humans.

桂皮(ケイヒ) (C4nnamoni Cortex
) :桂樹の樹皮であり、成分としてケイヒアルデヒド
、酢酸シンナミル等を含有し、ヒトの解熱、鎮痛、健胃
、整腸薬等として使用されている。
Cinnamon (C4nnamoni Cortex)
): It is the bark of the laurel tree, and contains cinnamyl acetate, cinnamyl acetate, etc., and is used as an antipyretic, analgesic, stomachic, and intestinal medicine for humans.

杜仲(トチュウ) (Eucommiae Corte
x) :杜仲ゴムの樹皮であり、成分としてグツタペル
カ等を含有し、ヒトの強壮薬等として使用されている。
Eucommiae Corte
x): It is the bark of the Duchu gum tree, and contains gutta percha as an ingredient, and is used as a tonic for humans.

枇杷$(ビワヨウ) (Eriobotryae Fo
lium) :枇杷の葉であり、成分としてウルソーン
、アミグダリン等を含有し、ヒトの健胃系として使用さ
れている。
Loquat $ (Eriobotryae Fo)
lium): Loquat leaves, containing ulsone, amygdalin, etc. as ingredients, and is used as a stomachic for humans.

連射(レンギヨウ)  (Forsythiae Fr
uctus):モクセイ科の落葉低木の1種である連射
の果実であり、成分としてオレアノール等を含有し、ヒ
トの解毒薬、排膿薬、消炎薬、利尿薬等として使用され
ている。
Rapid fire (Forsythiae Fr)
uctus): This fruit is a type of deciduous shrub in the Oleaceae family, and contains oleanol as a component, and is used as an antidote, purulent, anti-inflammatory, diuretic, etc. for humans.

本発明の予防および治療剤は、豚、牛、馬、山羊、めん
羊、うさぎ、犬、猫、ミンク、狐、不ズミ等の動物の仮
性狂犬病の予防および治療剤に使用することができ、特
に豚、牛、馬、めんよう、犬、猫等に対して使用した場
合には、畜産上、養豚産業上、ペット産業上大きな効果
をもたらす。
The prophylactic and therapeutic agent of the present invention can be used as a prophylactic and therapeutic agent for pseudorabies in animals such as pigs, cows, horses, goats, sheep, rabbits, dogs, cats, mink, foxes, and dogs. In particular, when used on pigs, cows, horses, chickens, dogs, cats, etc., it brings about great effects in the livestock industry, pig farming industry, and pet industry.

本発明の生薬を仮性狂犬病の予防用に使用し!−場合に
は、かかる生薬を投与しI;動物への仮性狂犬病の感染
が防止でき、またたとえ感染しても死亡には至らない場
合が多い。また、本発明の生薬を仮性狂犬病に感染した
動物の治療に使用した場合には、生存率が向上する。
Use the herbal medicine of the present invention to prevent pseudorabies! - In some cases, such herbal medicines can be administered to prevent animals from being infected with pseudorabies, and even if infected, it often does not lead to death. Furthermore, when the herbal medicine of the present invention is used to treat animals infected with pseudorabies, the survival rate is improved.

上記した本発明の生薬のうちでも丁字、荊芥、文集、蘇
葉および大黄が仮性狂犬病の予防および治療剤として効
果が高く、特に丁字が優れている。
Among the above-mentioned herbal medicines of the present invention, cloves, daisies, bunshu, soba, and rhubarb are highly effective as preventive and therapeutic agents for pseudorabies, and cloves are particularly excellent.

本発明の上記生薬を動物に投与するにあたっては、生薬
原体のままで、該生薬原体の切断物、粗粉砕物または粉
粒体の形態で、生薬の活性成分を水やその他の溶媒で抽
出した抽出液の形態で、或は該抽出液を希釈または濃縮
した形態で使用できる。該濃縮形態としては、活性成分
含有抽出液に対して更に濃縮、乾燥、抽出、沈澱等の濃
縮または分離手段を施すことによって活性成分を濃縮状
B(エキス)で含有する液状、半固形状、固形状物(塊
状、粉粒状、成塑製剤等)にしたものがあり、そのいず
れもが使用できる。
When administering the above-mentioned crude drug of the present invention to animals, the active ingredient of the crude drug is added to water or other solvent in the form of cut, coarsely ground, or powdered crude drug as it is. It can be used in the form of an extract, or in a diluted or concentrated form. The concentrated form includes a liquid or semi-solid form containing the active ingredient in a concentrated form B (extract) by further subjecting the active ingredient-containing extract to concentration or separation means such as concentration, drying, extraction, and precipitation; There are solid products (lumps, powders, plastic preparations, etc.), and any of them can be used.

そして、上記生薬中の活性成分を水やその他の溶媒で抽
出するに際しては、水、その他の溶媒または両者の混合
液中に生薬の原体、その粗粉砕物や粉末を入れ、浸漬、
煎じ等により活性成分を液体中に抽出して行うのがよい
。その際の液温および抽出処理時間は、生薬の種類、抽
出用液体の種類や量、成分の抽出し易さ、熱安定性、揮
発性の有無等の各種の要件に当然依存するが、一般には
、乾燥しI;生薬原体1gに対して抽出用液体約1〜l
ooomQを使用し、約4〜100℃の温度で、約30
分〜10日行うのがよい。
When extracting the active ingredients in the herbal medicines with water or other solvents, the raw materials of the herbal medicines, their coarsely ground products, or powders are placed in water, other solvents, or a mixture of the two, immersed,
It is preferable to extract the active ingredient into a liquid by decoction or the like. The liquid temperature and extraction processing time at that time naturally depend on various requirements such as the type of herbal medicine, the type and amount of extraction liquid, ease of extraction of ingredients, thermal stability, and the presence or absence of volatility, but in general is dried; approximately 1 to 1 liter of extraction liquid per 1 g of crude drug substance.
Using ooomQ, at a temperature of about 4 to 100℃, about 30
It is best to do this for 10 minutes to 10 days.

抽出処理は、静置下、撹拌下、震盪下のいずれの状態で
行ってもよい。
The extraction process may be performed in any state, standing still, stirring, or shaking.

活性成分の抽出に使用できる水以外の他の溶媒の例とし
ては、メタノール、エタノール、ブタノール、アセトン
、酢酸エチル、エーテル、塩化メチレン、クロロホルム
、ベンゼン、四塩化炭素、石油エーテル等を挙げること
ができる。
Examples of other solvents other than water that can be used to extract the active ingredient include methanol, ethanol, butanol, acetone, ethyl acetate, ether, methylene chloride, chloroform, benzene, carbon tetrachloride, petroleum ether, etc. .

そのうちでも抽出用液体としては水、メタノール、エタ
ノールまたはそれらの混合物が好ましく、特に水が好ま
しい。
Among these, water, methanol, ethanol, or a mixture thereof is preferred as the extraction liquid, and water is particularly preferred.

また、上記のようにして調製された活性成分含有抽出液
から活性成分を更にエキスとして濃縮回収する方法とし
ては、抽出液の溶媒を加熱下または非加熱下に部分的に
または完全に除去する方法、活性成分を沈澱剤等により
沈澱分離する方法、活性成分含有抽出液に別の溶媒を加
えてその別の溶媒中に活性成分を移行させて濃縮し必要
に応じ゛C該別の溶媒を除去する方法等が採用できる。
In addition, as a method for further concentrating and recovering the active ingredients as an extract from the active ingredient-containing extract prepared as above, there is a method of partially or completely removing the solvent of the extract with or without heating. , A method of separating the active ingredients by precipitation using a precipitating agent, etc. Adding another solvent to the active ingredient-containing extract, transferring the active ingredients into the other solvent, concentrating it, and removing the other solvent as necessary. A method such as that can be adopted.

生薬に含有されている活性成分の種類、活性成分の抽出
に使用しt:抽出溶媒の種類等に応じて、濃縮用の該別
の溶媒の種類を選択する必要があるが、通常、低級脂肪
族エーテル、低級ハロゲンアルカン類(クロロホルム、
ジクロロエタン、ジブロモエタン等)、芳香族炭化水素
(ベンゼン、トルエン、キシレン等)、その他の石油系
溶媒(石油エーテル、石油ベンゼン、リグロイン等)が
使用できる。
Depending on the type of active ingredient contained in the herbal medicine and the type of extraction solvent used to extract the active ingredient, it is necessary to select another solvent for concentration, but usually lower fats are used. group ethers, lower halogen alkanes (chloroform,
Dichloroethane, dibromoethane, etc.), aromatic hydrocarbons (benzene, toluene, xylene, etc.), and other petroleum solvents (petroleum ether, petroleum benzene, ligroin, etc.) can be used.

活性成分の抽出用および濃縮用に使用する溶媒が、動物
医薬上その含有が禁止されているものである場合には、
本発明の予防および治療剤に最終的に該溶媒が含まれな
いように充分精製することが必要である。
If the solvent used for extracting and concentrating the active ingredient is prohibited for veterinary medicine,
It is necessary to sufficiently purify the prophylactic and therapeutic agent of the present invention so that it does not ultimately contain the solvent.

本発明の予防および治療剤を動物に投与するにあたって
は、経口投与および非経口投与のいずれもが採用できる
。経口投与の場合は、上記生薬の原体、該原体の粗粉砕
物や粉末、活性成分含有抽出液、その濃縮エキス等をそ
のまま直接動物に給与するかまたは飼料や飲料水と一緒
にして給与することにより行う。また、非経口投与の場
合は、注射や塗布等による筋肉内投与、腹腔的投与、皮
下投与、経鼻投与、静脈内投与等のいずれもが採用でき
る。非経口投与の場合には活性成分を含有する抽出液ま
たはその濃縮液の形で使用するのがl利である。
In administering the prophylactic and therapeutic agent of the present invention to animals, both oral and parenteral administration can be employed. In the case of oral administration, the active ingredients of the herbal medicines, coarsely ground products or powders of the active ingredients, active ingredient-containing extracts, concentrated extracts, etc. of the above-mentioned herbal medicines can be fed directly to animals as they are, or together with feed or drinking water. Do by doing. In the case of parenteral administration, any of intramuscular administration by injection or coating, intraperitoneal administration, subcutaneous administration, nasal administration, intravenous administration, etc. can be adopted. For parenteral administration, it is advantageous to use the active ingredient in the form of an extract or its concentrate.

投与量は、生薬の種類、生薬の投与時の形態(例えば生
薬原体のままか、あるいは活性成分の抽出物か等)、動
物の種類や方今、投与形態(経口投与か又は非経口投与
か)、発病している場合はその症状等により異なるが、
経口投与の場合は、乾燥した生薬原体またはその粉砕物
や粉末に換算して、通常、0.001−1og/体重k
g/日の範囲で数日〜数十日に亘って投与するのが、ま
た非経口投与の場合は、乾燥した生薬夏休またはその粉
砕物や粉末に換算して、通常、0.01ff1g−1g
 /体X kg/ F3 ノ範囲で数日〜数十日に亘っ
て投与するのが好ましい。
The dosage depends on the type of crude drug, the form in which the crude drug is administered (for example, whether it is used as a crude drug or an extract of the active ingredient), the type of animal, and the mode of administration (oral or parenteral administration). ), and if the patient has developed the disease, it depends on the symptoms, etc.
In the case of oral administration, it is usually 0.001-1 og/kg of body weight in terms of dried herbal drug substance or its pulverized product or powder.
It is usually administered in the range of 0.01ff1g to 1g per day over several days to several tens of days, and in the case of parenteral administration, it is usually 0.01ff1g to 1g in terms of dried herbal medicine or its crushed product or powder.
It is preferable to administer the drug at a dose of 100 kg/body x kg/F3 over several days to several tens of days.

更に、本発明の予防および治療剤は、動物に投与するだ
けではなく消毒薬としても使用でき、その場合には該生
薬の抽出液を希釈して畜舎、器物およびその他必要な箇
所に散布するとよい。
Furthermore, the preventive and therapeutic agent of the present invention can be used not only for administration to animals but also as a disinfectant, and in that case, it is preferable to dilute the extract of the herbal medicine and spray it on livestock barns, equipment, and other necessary locations. .

その際の希釈液としては、生薬原体に換算して、0.0
0001〜1%W/Vの濃度のものを用いるのがよい。
At that time, the diluent should be 0.0 in terms of crude drug substance.
It is preferable to use one having a concentration of 0001 to 1% W/V.

以下に本発明を例を挙げて具体的に説明するが、本発明
はそれらの例により限定されない。
The present invention will be specifically explained below by giving examples, but the present invention is not limited by these examples.

例  1 ダルベツコ変法MEM培地0−05m12に仮性狂犬病
ウィルス含有液帆05mQ(2x 103PFU/m1
2液XPFUニブラック形成単位)を加え、この液をマ
イクロプレートに予め培養した豚腎細胞に接種し、37
℃の温度で1時間感作させ、そのときの仮性狂犬病ウィ
ルスのブラック数を数えt;(例1.−1:対照例)。
Example 1 Add 05 mQ of liquid containing pseudorabies virus (2x 103 PFU/m1) to 0-05 m12 of Dulbecco's modified MEM medium.
Add 2 liquids
The specimens were sensitized at a temperature of .degree. C. for 1 hour, and the number of black pseudorabies viruses was counted at that time (Example 1.-1: Control example).

別に乾燥した丁字末を5%V/Vとなるように蒸留水に
入れ、100℃の温度で30分間ゆっくり加熱して抽出
液を調製した。この抽出液を0.45μmのフィルター
で濾過滅菌し、10倍連続希釈液をそれぞれ調製した。
Separately, dried clove powder was placed in distilled water at a ratio of 5% V/V and slowly heated at 100° C. for 30 minutes to prepare an extract. This extract was sterilized by filtration using a 0.45 μm filter, and 10-fold serial dilutions were prepared.

この10倍連続希釈液の各々0−05rnnに上記対照
例1で使用したのと同じ仮性狂犬病ウィルス含有液を各
々0−05m+2を加え、37℃で1時間感作させ、そ
のときの仮性狂犬病ウィルスのブラック数が上記対照例
1の50%以下を示す最大希釈倍率の希釈液を求めf−
(例1−2=実施例)。
0-05m+2 of the same pseudorabies virus-containing solution used in Control Example 1 was added to each 0-05rnn of this 10-fold serial dilution solution, and sensitized at 37°C for 1 hour. Determine the diluent with the maximum dilution ratio in which the black number of f- is 50% or less of that of Control Example 1.
(Example 1-2=Example).

丁字末の代わりに荊芥、文集、蘇葉、火責、甘草、牡丹
皮、芍薬、十薬、菌陳高、金銀花、桂皮、杜仲、枇杷案
および連暉の粉末を使用して上記例1−2と同様にして
仮性狂犬病ウィルスのブラック数が上記対照例1の50
%以下を示す最大希釈倍率の希釈液を求めた(例1−3
〜1−xa:実施例)。
In the above example 1, powders of Jinghuan, Wenzhu, Su Ye, Huizan, Licorice, Peony bark, Paeonia, Juyaku, Bacterium Chengao, Jinyinhua, Cinnamon bark, Duzhong, Duzhong, Loquat and Lianhui were used in place of the end of the clove. -2, the black number of pseudorabies virus was 50 in control example 1 above.
% or less was determined (Example 1-3
~1-xa: Example).

上記の結果を下記の第1表に示す。The above results are shown in Table 1 below.

[第 1 表] 丁字  10’    十薬  10”荊芥  10”
    菌暉萬  10’交 葉    io3金銀花
     10”蘇葉  101    桂皮  10
8大黄io”    杜仲  10’ 甘 草    10”        枇杷葉    
 102牡丹皮    10”        連 a
      io’荀薬  10! 上記第1表の結果から、丁字、荊芥、文集、蘇葉、大黄
、甘草、牡丹皮、巧薬、十薬、菌暉萬、金銀花、桂皮、
杜仲、枇杷葉および連剋のいずれの場合も、それらの抽
出液を100倍以上に希釈した場合ですらも、該生薬を
含有しない対照例1−1に比べて、仮性狂犬病ウィルス
の増殖を50%以下に抑制し得ることがわかる。更に、
該第1表の結果から、丁字が一番効果があり、これに荊
芥、文集、蘇葉および大黄が続くことがわかる。
[Table 1] Clove 10' Juyaku 10" Jingkuta 10"
Bacteria perilla 10' cross leaf io3 gold and silver flower 10" So leaf 101 cinnamon 10
8 Rhubarb io” Moritake 10’ Licorice 10” Loquat leaf
102 Botanpi 10” series a
io'Xun Yao 10! From the results in Table 1 above, we can see that clove, peony, wenzhu, soba, rhubarb, licorice, peony bark, takuyaku, ten medicines, fungi human, gold and silver flower, cinnamon,
In the case of any of the extracts of Mori zhong, Loquat leaf and Lianku, even when their extracts were diluted 100 times or more, the growth of pseudorabies virus was reduced by 50% compared to Control Example 1-1 which did not contain the herbal medicine. % or less. Furthermore,
From the results in Table 1, it can be seen that clove is the most effective, followed by Jinghu, Wenzhu, Suyou, and Rhubarb.

例  2 乾燥した丁字末を5%v/vになるように蒸留水に入れ
、100°Cの温度で30分間ゆっくり加熱して抽出液
を調製した。この抽出液の上澄みを水で5倍に希釈し、
この液のみを給水ビンに入れて4匹のマウス(BALB
/ C早 6週令)に3日間自由に摂取させた後、仮性
狂犬病ウィルスをio”PFU/匹の割合でその腹腔内
に投与し感染させ、その後更に上記の5倍希釈丁字抽出
液を5日間自由に摂取させた。仮性狂犬病ウィルス投与
感染5日後に生存数は2匹であった(例2−1:実施例
)。
Example 2 Dry clove powder was added to distilled water to give a concentration of 5% v/v and slowly heated at 100°C for 30 minutes to prepare an extract. The supernatant of this extract was diluted 5 times with water,
Add this solution only to a water bottle and feed 4 mice (BALB
After feeding the animals freely for 3 days, the pseudorabies virus was administered intraperitoneally at a rate of io''PFU/animal to infect them, and then the above 5-fold diluted clove extract was administered to the animals for 5 days. Five days after pseudorabies virus administration, two animals survived (Example 2-1: Example).

上記の5倍希釈丁字抽出液を滅菌後、4匹のマウス(B
ALB/ C早 6週令)の腹腔内に0.2an/匹/
回の割合で2回投与した。これに仮性狂犬病ウィルスを
IO”PFtJ/匹の割合でその腹腔内に投与し感染さ
せ、たところ、仮性狂犬病ウィルス投与感染5日後の生
存数は3匹であった(例2−2:実施例)。
After sterilizing the above 5-fold diluted clove extract, 4 mice (B
0.2an/mouse/intraperitoneally of ALB/C (early 6 weeks old)
It was administered twice at the same time. Pseudorabies virus was intraperitoneally administered to these animals at a rate of IO"PFtJ/animal to infect them. As a result, the number of surviving animals after 5 days of pseudorabies virus administration and infection was 3 (Example 2-2: Example ).

比較のため、4匹のマウス(BALB/ C子 6週令
)の腹腔内に生理食塩水を0 、2an/匹/回の割合
で2回投与した後、これに仮性狂犬病ウィルスを10’
PFU/匹の割合でその腹腔内に投与し感染させたとこ
ろ、仮性狂犬病ウィルス投与感染5日後の生存数は0匹
であった(例2−3:比較例)。
For comparison, four mice (BALB/C pups, 6 weeks old) were intraperitoneally administered with physiological saline twice at a rate of 0 and 2 an/mouse/time, and then pseudorabies virus was administered for 10'.
When the pseudorabies virus was administered intraperitoneally to the animals at a rate of PFU/animal to infect them, the number of surviving animals 5 days after the administration of pseudorabies virus was 0 (Example 2-3: Comparative Example).

上記の結果から、丁字抽出物を含有する本発明の剤が、
動物の仮性狂犬病の予防および治療に有効であることが
わかる。
From the above results, it is clear that the agent of the present invention containing clove extract
It is found to be effective in preventing and treating pseudorabies in animals.

例  3 乾燥した蘇集末および犬黄末を5%w/vになるように
蒸留水に入れ、100°Cの温度で30分間ゆっくり加
熱して抽出液を調製した。これらの抽出液の上澄みをそ
れぞれ水で5倍に希釈し、これらの液のみを給水ビンに
入れて3匹のマウス(BALB/C子 6週令)に7日
間自由に摂取させた後、仮性狂犬病ウィルスを10’P
FU/匹の割合で経口的に投与し感染させ、その後更に
上記の5倍希釈各抽出液を5日間自由に摂取させた。仮
性狂犬病ウィルス投与感染5日後に生存数はそれぞれ1
匹ずつであった(例3−1:実施例)。
Example 3 Dried Suji Powder and Dog Yellow Powder were added to distilled water at a concentration of 5% w/v and slowly heated at a temperature of 100°C for 30 minutes to prepare an extract. The supernatants of these extracts were each diluted 5 times with water, and these liquids alone were placed in a water bottle and allowed to be freely ingested by three mice (BALB/C offspring, 6 weeks old) for 7 days. Rabies virus 10'P
The animals were orally administered at a rate of FU/animal to infect them, and then allowed to freely ingest each of the above 5-fold diluted extracts for 5 days. After 5 days of pseudorabies virus administration, the number of survivors was 1 for each.
(Example 3-1: Example).

比較のため水のみを給水ビンに入れて3匹のマウスを7
日間飼育した後、これに仮性狂犬病ウィルスをio’P
FU/匹の割合で経口的に投与し感染させたところ仮性
狂犬病ウィルス投与感染5日後の生存数は0匹であった
(例3−2:比較例)。
For comparison, three mice were placed in a water bottle containing only water.
After raising it for several days, it was infected with pseudorabies virus by io'P.
When infected by orally administering the pseudorabies virus at a ratio of FU/animal, the number of surviving animals 5 days after the administration of pseudorabies virus was 0 (Example 3-2: Comparative Example).

上記の結果から、蘇葉および大黄抽出物を含有する本発
明の剤が、動物の仮性狂犬病の予防および治療に有効で
あることがわかる。
The above results demonstrate that the agent of the present invention containing Soo leaf and Rhubarb extract is effective in preventing and treating pseudorabies in animals.

例  4 乾燥した丁字末を10%w/vになるように水に入れ、
60分間加熱沸騰させて抽出液を調製した。
Example 4 Put dried clove ends in water at 10% w/v,
An extract was prepared by heating and boiling for 60 minutes.

この抽出液の上澄液を妊娠豚に100mff7頭/日に
なるように飼料に加えて分娩の1週間前から離乳まで投
与した。この結果、この付近の養豚場では仮性狂犬病に
よる哺乳豚の被害が発生していだにも拘らず、丁字抽出
液を投与したこの妊娠豚から生まれた哺乳豚には仮性狂
犬病の発生が見られなかった。
The supernatant liquid of this extract was added to the feed of pregnant pigs at 100 mff/7 pigs/day and administered from one week before farrowing until weaning. As a result, pseudorabies was not found in the suckling pigs born from this pregnant pig to which the clove extract was administered, despite the fact that pseudorabies had caused damage to suckling pigs at nearby pig farms. Ta.

例  5 丁字の粉末を0.5を量%含有する飼料を豚(a退会)
20Mに60日間に亘って自由に摂取させた。
Example 5 Pig feed containing 0.5% clove powder (a withdrawal)
20M was given ad libitum over 60 days.

この結果、付近の養豚場では仮性狂犬病が発生していた
にも拘らず、丁字粉末を投与したこれらの豚からは仮性
狂犬病の発生が見られなかっIこ 。
As a result, no outbreak of pseudorabies was observed in these pigs treated with clove powder, even though pseudorabies had occurred at a nearby pig farm.

例  6 実施例2−1で調製した丁字の濾過後の抽出液を水で1
0000倍に希釈して豚舎に散布した。
Example 6 The filtered clove extract prepared in Example 2-1 was mixed with water for 1 hour.
It was diluted 1:0,000 and sprayed on pig pens.

この結果、付近の養豚場では仮性狂犬病が発生していた
にも拘らず、希釈した丁字抽出液を散布したこの豚舎か
らは仮性狂犬病の発生が見られなかっt;。
As a result, although pseudorabies had occurred at a nearby pig farm, no outbreak of pseudorabies was observed in this pigpen where the diluted clove extract was sprayed.

[発明の効果] 本発明では、丁字、荊芥、文集、蘇葉、大賞、甘草、牡
丹皮、荀薬、十薬、菌暉萬、金銀花、桂皮、杜仲、枇杷
葉および連射からなる群から選ばれる生薬の1種または
2種以上を活性成分として含有することを特徴とする動
物の仮性狂犬病の予防および治療剤とすることによって
、手間等がかからず、しかもワクチンを投与した場合に
生じる強毒性ウィルスの形成や動物体内でのワクチンの
残留等の問題を生ずることなく仮性狂犬病の予防および
治療を極めて効果的に行うことができる。
[Effects of the Invention] In the present invention, from the group consisting of clove, peony, Bunshu, Suyou, Dasho, licorice, peony bark, Xun medicine, ten medicines, fungi human, gold and silver flower, cinnamon, Du Zhong, loquat leaf, and rapid fire. The prevention and treatment of animal pseudorabies, which is characterized by containing one or more selected crude drugs as active ingredients, does not require much effort, and can also be used to treat pseudorabies that occurs when a vaccine is administered. Pseudorabies can be extremely effectively prevented and treated without causing problems such as the formation of a highly virulent virus or residual vaccine in the animal's body.

Claims (1)

【特許請求の範囲】[Claims] 丁字、荊芥、艾葉、蘇葉、大黄、甘草、牡丹皮、芍薬、
十薬、茵■蒿、金銀花、桂皮、杜仲、枇杷葉および連翹
からなる群から選ばれる生薬の1種または2種以上を活
性成分として含有することを特徴とする動物の仮性狂犬
病の予防および治療剤。
Clove, Peony leaves, Soba leaves, Rhubarb, Licorice, Peony skin, Peony leaves,
Prevention of pseudorabies in animals, characterized by containing as an active ingredient one or more of the herbal medicines selected from the group consisting of 10 medicines, 茵蒿, 金和花, cinnamon, Du Zhong, loquat leaves, and Lianxiang. therapeutic agent.
JP1076621A 1989-03-30 1989-03-30 Prevention and treatment of pseudorabies in animals Expired - Fee Related JP2701930B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1076621A JP2701930B2 (en) 1989-03-30 1989-03-30 Prevention and treatment of pseudorabies in animals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1076621A JP2701930B2 (en) 1989-03-30 1989-03-30 Prevention and treatment of pseudorabies in animals

Publications (2)

Publication Number Publication Date
JPH02258725A true JPH02258725A (en) 1990-10-19
JP2701930B2 JP2701930B2 (en) 1998-01-21

Family

ID=13610422

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1076621A Expired - Fee Related JP2701930B2 (en) 1989-03-30 1989-03-30 Prevention and treatment of pseudorabies in animals

Country Status (1)

Country Link
JP (1) JP2701930B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7524518B2 (en) 2001-05-11 2009-04-28 Kim Sung-Jin Composition for promoting regeneration of hard tissues comprising an extract of cortex eucommiae

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7524518B2 (en) 2001-05-11 2009-04-28 Kim Sung-Jin Composition for promoting regeneration of hard tissues comprising an extract of cortex eucommiae

Also Published As

Publication number Publication date
JP2701930B2 (en) 1998-01-21

Similar Documents

Publication Publication Date Title
JP3007665B2 (en) Preventive and therapeutic agent for coronavirus infection and disinfectant
CN1985922A (en) Medicine composition for treating common cold and its preparing method
CN114470042B (en) Composition for preventing and treating liver injury of animals as well as preparation method and application thereof
CN104825700A (en) Traditional Chinese medicine composition for resisting bacteria and diminishing inflammation
JP2535555B2 (en) Agent for preventing and treating streptococcal disease in fish
JP2701930B2 (en) Prevention and treatment of pseudorabies in animals
AU2004229119A1 (en) Herbal composition
CN110721256B (en) Traditional Chinese medicine composition for preventing and treating teniasis of laying hens and preparation method thereof
CN100363043C (en) Chinese traditional medicine composition for treating rheumatic or rheumatoid disease and preparation method thereof
CN107233454B (en) Traditional Chinese medicine and Tibetan medicine composition for preventing and treating livestock diarrhea
CN103169825A (en) Drug for treating enteric disease of beasts and birds
CN102302575B (en) Oral medicament for treating white scour of piglets and preparation method thereof
CN104784327A (en) Traditional Chinese veterinary medicine composition for treating respiratory diseases of chicken and preparation method thereof
JPH01238532A (en) Antiinfectant
CN102008593B (en) Animal antibacterial and anti-virus Chinese medicinal composition and preparation method thereof
Herdiana et al. Veterinary Drug Development from Indonesian Herbal Origin: Challenges and Opportunities
JP2821211B2 (en) Prophylactic and therapeutic agent for Klebsiella pneumoniae infection
CN115671192B (en) Traditional Chinese medicine composition for preventing and treating taeniasis of ducks
CN111434348A (en) Medicine for treating plague of livestock
JP3286408B2 (en) Prevention and treatment of Aujeszky's disease
CN103933121B (en) A kind of Chinese medicine composition demonstrate,proved for livestock and poultry diseases caused by external factors and preparation method thereof
CN108465098B (en) Traditional Chinese medicine composition for preventing and treating poultry Newcastle disease
KR102010724B1 (en) Natural feed additive composition and its preventive and therapeutic effect on Myxozoa
CN107441267B (en) Pharmaceutical composition for preventing and treating livestock diarrhea
JP2818668B2 (en) Prevention and treatment of Pseudomonas aeruginosa infection

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20071003

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081003

Year of fee payment: 11

LAPS Cancellation because of no payment of annual fees